Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
NCT03731910
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST:
MRI
Sponsor
Seoul National University Hospital
Collaborators
[object Object]